Professor Ofer Shpilberg – oncologist, oncologist-hematologist, renowned specialist in Israel, practicing in the treatment of leukemia, anemia, myeloma and lymphocytic leukemia. Heads Clinical Research Center at Dynamix Pharmaceuticals Ltd. He uses complex methods in the treatment of patients: bone marrow transplantation, targeted chemotherapy and radiotherapy with the latest equipment. Studied medicine at the Ben-Gurion University of the Negev. He specialized in hematology and hematology oncology at the clinic at Tel Aviv University, received a master’s degree. Graduated from the Department of Health Systems Management at the American University of Pittsburgh. Founder of the Laboratory for Molecular Research in the Fight against Cancer. President of the Israeli and European Hematology Associations.
blood cancer treatment;
treatment of acute and chronic leukemia;
diagnosis and treatment of Hodgikin's disease and non-Hodgikin lymphoma.